Kalmbach Thomas Peter 4

What Happened

• Thomas P. Kalmbach, EVP & CFO of Globe Life (GL), exercised stock derivatives to acquire 35,000 shares (15,000 on 2026-05-08 and 20,000 on 2026-05-11) at $98.32 each (total cost $3,441,200). He then sold 27,427 shares in open-market transactions across the two dates for an aggregate proceeds of approximately $4,195,007.
• The filing shows derivative “disposed” entries at $0.00 for the exercised lots, consistent with option conversion/settlement, and the open-market sales were executed at prices roughly between $151.38 and $154.365 per share.

Key Details

• Transaction dates: 2026-05-08 and 2026-05-11; Form 4 filed 2026-05-12 (appears to be within the standard reporting window).
• Exercise detail: 15,000 shares @ $98.32 (5/8) = $1,474,800; 20,000 shares @ $98.32 (5/11) = $1,966,400.
• Sales detail: total 27,427 shares sold for total proceeds ≈ $4,195,007; reported sale price ranges across filings: $151.38–$152.47, $153.04–$154.02, and $154.08–$154.365 (reporting person will provide full per-price breakdown on request).
• Shares owned after the transactions: not specified in the information provided in this summary.
• Footnote: includes 7.6337 dividend-equivalent restricted stock units acquired since last report.

Context

• This looks like an exercise of options followed by substantial open-market sales (often referred to as a cashless or partial cashless exercise when exercised shares are sold to cover costs/taxes), though the filing is factual and does not state motivations.
• For retail investors: exercises plus immediate sales are common for executives managing tax and exercise costs; purchases would be a stronger bullish signal. This filing reports material insider activity but does not by itself indicate a change in company outlook.